Invion is a clinical-stage life-sciences company that is leading the global clinical development of the Photosoft™ technology for the treatment of cancers. Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of Photosoft™. The appointment has been made by technology licensor, The Cho Group, a Hong Kong based group that has funded and successfully commercialised a number of unique and advanced technologies. Via an R&D services agreement between the two entities, the research and clinical trials of Photosoft™ are funded by The Cho Group. Invion has an alliance with leading Australian medical research institute, Hudson Institute of Medical Research, for the Photosoft™ research program.
Company Details
- Employees
- 10
- Founded
- 2012
- Address
- 100 Albert Rd, South Melbourne,victoria 3205,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- invion.com.au
- Keywords
- Clinical-stage pharmaceutical drug development, FDA-regulated clinical trial design, asthma and COPD, systemic lupus erythematosus.
- HQ
- South Melbourne, Victoria
Invion Limited Questions
Invion Limited's website is invion.com.au
Invion Limited's LinkedIn profile is https://au.linkedin.com/company/invion-limited
Invion Limited has
10 employees.
View email and phone details for 10
employees at Invion Limited.
Invion Limited's industry is
Biotechnology Research
Invion Limited's categories are Biotechnology Research
Invion Limited's founding year is 2012
